Analysis the Effectiveness of Remdesivir, Galidesivir, Sofosbuvir, Tenofovir and Ribavirin as Potential Therapeutic Drug target against SARS-Cov-2 RNA-Dependent RNA Polymerase (RdRp): An in Silico Docking Study
Background & Aims: The active site of RdRp-CoV is highly conserved, with two successive and surface-accessible aspartates in a beta-turn structure. Antiviral drugs Remdesivir, Galidesivir, Tenofovir, Sofosbuvir, and Ribavirin are known as inhibitors of RdRps, while lopinavir and rotinavir are k...
Main Authors: | Rajneesh Prajapat, Suman Jain |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
Urmia University of Medical Sciences
2023-07-01
|
Serija: | Journal of Research in Applied and Basic Medical Sciences |
Teme: | |
Online dostop: | http://ijrabms.umsu.ac.ir/article-1-261-en.pdf |
Podobne knjige/članki
-
Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2
od: Thirumal Kumar D, et al.
Izdano: (2021-04-01) -
SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System
od: Jung Sun Min, et al.
Izdano: (2021-08-01) -
In silico study of the flavonoid compound of Sauropus androgynus leaves ON RNA-Dependent RNA polymerase (RdRp) SARS-CoV-2
od: Aghnia Nabila Ananda, et al.
Izdano: (2024-06-01) -
Influence of SARS-CoV-2 variants’ spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues
od: Ali A. Dawood
Izdano: (2022-07-01) -
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp)
od: Anandakrishnan Karthic, et al.
Izdano: (2022-01-01)